Browse Biological products industry topic

Mergers, acquisitions and divestments subtopic

Articles

1-100 out of 100 article(s)

Title	Author	Type	Date	Words
China : Simcere Pharmaceutical Group to Acquire Additional Stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd.			Oct 29, 2009	246
United States : Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer.			Oct 27, 2009	447
Entest BioMedical Announces Intent to Acquire Cancer Research Company Therinject LLC.			Oct 21, 2009	333
Mountain West Business Solutions Acquires Sunshine Biopharma.			Oct 20, 2009	413
Biogen Idec Extends Offer to Acquire Facet Biotech Corporation for $14.50 Per Share in Cash.			Oct 16, 2009	2046
BioSante Pharmaceuticals and Cell Genesys Announce Completion of Merger.			Oct 14, 2009	1491
BioSante Pharmaceuticals and Cell Genesys Announce Approval of Merger by BioSante Stockholders and Adjournment of Cell Genesys Stockholders Meeting Until October 14, 2009.			Sep 30, 2009	1752
BioSante Pharmaceuticals and Cell Genesys Announce Final Exchange Ratio for Merger.			Sep 22, 2009	1428
Biogen Idec Reiterates Proposal to Acquire All Outstanding Shares of Facet for $14.50 Per Share in Cash.			Sep 8, 2009	742
Biogen Idec Announces Proposal to Acquire All Outstanding Shares of Facet for $14.50 per Share in Cash.			Sep 4, 2009	1567
BioSante Pharmaceuticals and Cell Genesys Announce September 30, 2009 Special Stockholders Meetings to Approve Merger.			Sep 3, 2009	2090
Bristol-Myers Squibb Completes Acquisition of Medarex, Inc.			Sep 1, 2009	243
Singapore : Roche buys Singapore facility from Lonza.			Sep 1, 2009	460
Bristol-Myers Squibb Announces Expiration of Hart-Scott-Rodino Review Period for Acquisition of Medarex, Inc.			Aug 12, 2009	850
Bristol-Myers Squibb Begins Tender Offer to Acquire Medarex, Inc.			Jul 28, 2009	1041
Bristol-Myers Squibb to Acquire Medarex.			Jul 22, 2009	1788
BioSante Pharmaceuticals and Cell Genesys Sign Definitive Merger Agreement.			Jun 30, 2009	2136
Drug Companies Abandon Merger Plans After FTC Challenge.	Singer, Toby		Jun 24, 2009	743
Gilead Sciences Completes Acquisition of CV Therapeutics.			Apr 17, 2009	371
StemCells, Inc. Closes Its Acquisition of the Operating Assets and Businesses of Stem Cell Sciences Plc.			Apr 1, 2009	867
Roche reshuffling operations in $46b Genentech deal.	Chambers, Heather		Mar 23, 2009	228
United States: Astellas Drops Hostile Bid for CV Therapeutics.			Mar 17, 2009	378
United States: Astellas Pharma Abandons Offer To Buy CV Therapeutics.			Mar 17, 2009	376
Gilead Sciences Agrees to Acquire CV Therapeutics for $20.00 Per Share.			Mar 12, 2009	1750
Roche buys rest of Genentech for [pounds sterling]34bn.			Mar 12, 2009	173
Enzo Biochem Acquires Assay Designs, Inc. Further Expanding Life Sciences Operations.			Mar 12, 2009	777
Astellas Commences Tender Offer to Acquire All Outstanding Shares of CV Therapeutics for $16.00 Per Share in Cash.			Feb 27, 2009	1435
Roche starts hostile bid for Genentech.			Jan 31, 2009	197
Astellas Proposes to Acquire CV Therapeutics for $16 Per Share in Cash.			Jan 27, 2009	1470
Stem cell grant maker branches out: a governing board for the state stem cell agency voted to approve more than $19 million in funding for a new round of grants intended to accelerate stem cell research.	Chambers, Heather	Brief article	Dec 15, 2008	165
United States: Roche still seeking loan for Genentech bid.			Dec 3, 2008	206
United States: Nobel Biocare to acquire BioCad Medical for about EUR 26 mln (USD $ 32.69 Mln).			Nov 16, 2008	182
United Kingdom: BIOGEN acquires Greenfinch in AD technology merger.			Nov 3, 2008	457
Cristal Union acquires stake in Burgundy.			Nov 1, 2008	342
Critical Therapeutics, Inc. Announces Stockholder Approvals Related to Merger with Cornerstone BioPharma Holdings, Inc. and 10-to-1 Reverse Stock Split.			Oct 31, 2008	752
Critical Therapeutics, Inc. Announces Effectiveness of Registration Statement for the Proposed Merger with Cornerstone BioPharma Holdings, Inc.			Oct 3, 2008	1079
Cornerstone Completes Merger with Critical Therapeutics.			Oct 1, 2008	529
United States : Arca Biopharma merging with California company.			Sep 26, 2008	303
BioTime, Inc. Conference Call Will Discuss Its Recent Acquisition of Stem Cell Technology Licenses.			Sep 11, 2008	535
United Kingdom: Ondine Biopharma buys license for gold-nanoparticle photosensitizer from UCL.			Jul 30, 2008	89
France : Acambis agrees 276 mln stg bid from Sanofi Pasteur.			Jul 28, 2008	84
Roche shows mega-deal alive with Genentech bid.			Jul 21, 2008	319
Roche to buy out Genentech for $43.7bn.			Jul 21, 2008	133
Turkey: Pharming Group inks 5-year supply deal with Aslan.			Jul 17, 2008	130
Embryome Sciences, Inc. Acquires Exclusive License for ACTCellerate Technology.			Jul 16, 2008	960
Allergan Completes Acquisition of Aczone Gel 5%.			Jul 14, 2008	792
Inovio merges with East Coast firm to advance vaccine development: combined company to operate R&D facility in Sorrento Valley.	Chambers, Heather		Jul 14, 2008	579
Q1 revenues, income soar at RTI Biologics.		Brief article	Jul 1, 2008	314
Bristol-Myers Squibb Completes Acquisition of Kosan Biosciences Incorporated.			Jun 26, 2008	418
Bristol-Myers Squibb Announces Expiration of Hart-Scott-Rodino Review Period for Acquisition of Kosan Biosciences Incorporated.			Jun 18, 2008	469
United States: Allergan Buys Acne Drug From QLT for $150 Million.			Jun 10, 2008	219
Allergan Announces Agreement to Acquire Aczone(R) Gel 5%.		Clinical report	Jun 9, 2008	1167
Essel Propack builds its US presence with latest acquisition.			Jun 1, 2008	231
Iranex group acquires Bio Serae.		Brief article	Jun 1, 2008	82
Bristol-Myers Squibb to Acquire Kosan Biosciences.			May 29, 2008	1811
Bristol-Myers Squibb Begins Tender Offer to Acquire Kosan Biosciences Inc.			May 29, 2008	774
Mymetics Corporation Acquires Preventive Malaria Vaccine From Pevion Biotech AG (Switzerland).			May 19, 2008	913
Enzo buys reagent firm.		Brief article	May 15, 2008	223
Enzo Biochem Acquires BIOMOL International, Further Expanding Its Life Sciences Operations.			May 9, 2008	822
Critical Therapeutics Signs Definitive Agreement to Merge with Cornerstone BioPharma.			May 1, 2008	2313
Regeneration Technologies, Tutogen Medical complete merger to form RTI Biologics.		Company overview	Apr 1, 2008	151
AVI BioPharma Announces Close of Ercole Biotech Acquisition.			Mar 24, 2008	595
AVI BioPharma Announces Acquisition of Ercole Biotech.			Mar 13, 2008	1196
AVANT Announces Completed Merger with Celldex and 1-for-12 Reverse Stock Split.			Mar 7, 2008	1154
Regeneration Technologies, Tutogen Medical Merger Completed.			Feb 27, 2008	580
Acorda Therapeutics Announces Acquisition of Aminopyridine and Pre-Clinical Assets from Neurorecovery, Inc.			Feb 4, 2008	607
CELL THERAPEUTICS ACQUIRES ZEVLIN FROM BIOGEN IDEC.			Feb 1, 2008	969
Regeneration Technologies, Tutogen Medical Announce New Name for Proposed Merged Company.			Jan 17, 2008	1307
Regeneration Technologies, Tutogen Medical Set Special Meeting of Stockholders to Vote on Proposed Merger.			Jan 14, 2008	1292
MPM BioEquities Demands VaxGen Drop Merger Plan with Raven.			Dec 12, 2007	623
Natraceutical acquires Cevena.		Brief article	Dec 1, 2007	116
Cell Therapeutics completes acquisition of lymphoma drug Zevalin from Biogen Idec for sales and marketing in the United States.			Dec 1, 2007	920
Pfizer to Acquire Coley Pharmaceutical Group.			Nov 16, 2007	972
Regeneration Technologies, Tutogen Medical Announce Agreement to Merge.			Nov 13, 2007	2036
Amarin signs agreement to acquire Ester Neurosciences.			Nov 1, 2007	1632
Icahn and Idec?	Chambers, Heather	Brief article	Oct 22, 2007	176
AVANT Immunotherapeutics, Inc. and Celldex Therapeutics, Inc. Announce Merger Agreement.			Oct 22, 2007	2133
Cyclacel Pharmaceuticals Acquires Specialty Pharmaceutical Business Focused on the Oncology Market.			Oct 8, 2007	1736
Shareholders Approve Inhibitex Acquisition of FermaVir.			Sep 20, 2007	718
Genentech Announces Expiration of Hart-Scott-Rodino Waiting Period and Completes Acquisition of Tanox.			Aug 2, 2007	372
Diversa merges with Massachusetts biofuels company.	Weeks, Katie		Jul 9, 2007	93
Enzo Life Sciences, Inc., Completes Acquisition of Axxora Life Sciences, Inc.			Jun 5, 2007	466
Enzo Biochem Unit to Acquire Axxora Life Sciences, Inc. Global Reagent Manufacturer and Marketing Company.			May 30, 2007	844
Invitrogen acquires Cascade Biologics.		Brief article	May 15, 2007	117
AstraZeneca sets out takeover offer.			May 5, 2007	61
Research & Markets: Gilead Sciences Acquisitions of Myogen and Corus Pharma Has Significantly Expanded the Scope of Their Research Efforts.			Apr 19, 2007	522
FermaVir Pharmaceuticals, Inc. Signs Definitive Agreement to Be Acquired by Inhibitex, Inc.			Apr 10, 2007	1299
Inhibitex Signs Definitive Agreement to Acquire FermaVir Pharmaceuticals.			Apr 10, 2007	1957
Subsidiary for sale.	Graves, Brad	Brief article	Feb 19, 2007	80
Invitrogen to sell BioReliance for a $290 million loss.		Brief article	Feb 15, 2007	256
Biogen Idec to Acquire Syntonix.			Jan 4, 2007	1005
NextGen entered the gene synthesis market in August by acquiring a license to Gene Oracle's GeneIOS gene synthesis products and services in exchange for technology transfer fees and royalties.		Brief article	Nov 30, 2006	51
Biopharma Deal Making: A Focus On Genitourinary/Gynecology.			Nov 23, 2006	273
Comprehensive Summary Of Biopharma Deals For 2006.			Nov 20, 2006	294
Biopharma Deals 2006: Focus on Metabolic Diseases.			Nov 20, 2006	287
Gilead Sciences Completes Acquisition of Myogen.			Nov 17, 2006	342
Comprehensive Summary of Deals Made in Biopharma's Autoimmune/Inflammation Sector in 2005 Now Available.			Nov 13, 2006	357
Enzo Biochem Acquires License to Six Key RNA Amplification Patents.			Oct 13, 2006	563
Gilead Sciences to Acquire Myogen, Inc. for $2.5 Billion.			Oct 2, 2006	1622
Acquisitions.			Aug 1, 2002	371